COVID-19 Study of Safety and Tolerability of Alvelestat
Clinical trial NCT04539795 · COMPLETED
Trial details
- NCT number
- NCT04539795
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2021-10-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.